In contrast, drug repositioning can take 34 years to reach clinical trials (Sams-Dodd, 2005)
Temporal trends in discontinuation reasons were described across the study period
Conclusions Of the metabolic approaches discussed above, creatine, dexpramipexole, olesoxime, MitoQ and Coenzyme Q have been investigated in randomized clinical trials (summarized in Table 1)
The flavor of botanical drugs is mainly sweet, bitter, and pungent
Comparative proteomic analysis of lysine acetylation in Trypanosomes
Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: a systematic review and meta-analysis of randomized controlled trials